MAS1 and cystic fibrosis: In MAS clinical isolates from non-CF patients in Japan and Taiwan, 21 out of 105 (20%) belonged to MAS_GL1.2 or MAS-GL1.3, whereas 30 (28.6%) belonged to MAS-GL1.1 (Fig. 3).